Graboyes Evan M, Townsend Melanie E, Kallogjeri Dorina, Piccirillo Jay F, Nussenbaum Brian
Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St Louis, Missouri.
Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St Louis, Missouri2Editor, JAMA Otolaryngology-Head & Neck Surgery.
JAMA Otolaryngol Head Neck Surg. 2016 Dec 1;142(12):1154-1163. doi: 10.1001/jamaoto.2016.0657.
Quality metrics for patients with laryngeal squamous cell carcinoma (SCC) exist, but whether compliance with these metrics correlates with improved survival is unknown.
To examine whether compliance with proposed quality metrics is associated with improved survival in patients with laryngeal SCC treated with surgery with or without adjuvant therapy.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included patients from a tertiary care academic medical center who had previously untreated laryngeal SCC and underwent surgery with or without adjuvant therapy from January 1, 2003, through December 31, 2012. Data analysis was performed from August 4, 2015, through December 13, 2015.
Surgery with or without adjuvant therapy.
Compliance with quality metrics from the American Head and Neck Society (AHNS), National Comprehensive Cancer Network (NCCN) guidelines, and institutional metrics with face validity covering pretreatment evaluation, treatment, and posttreatment surveillance was evaluated. The association between compliance with the group of metrics and overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS) was explored using Cox proportional hazards analysis. The association between compliance with individual metrics and survival was similarly determined.
A total of 243 patients (184 men and 59 women) were included in the study (median age, 62 years; age range, 23-87 years). No association was found between increasing levels of compliance with the AHNS or NCCN metrics and survival. The only AHNS or NCCN metric for which greater compliance correlated with improved survival on multivariable Cox proportional hazards analysis controlling for pT stage, pN stage, extracapsular spread, margin status, and comorbidity was pretreatment multidisciplinary evaluation for patients with stage cT3-4 or cN1-3 disease (OS adjusted hazard ratio [aHR], 0.47; 95% CI, 0.24-0.94; DFS aHR, 0.45; 95% CI, 0.23-0.85). For the institutional metrics, multidisciplinary evaluation for all patients (OS aHR, 0.51; 95% CI, 0.29-0.88; DFS aHR, 0.50, 95% CI, 0.32-0.80) and elective neck dissection yield of 18 lymph nodes or more (DFS aHR, 0.36; 95% CI, 0.14-0.99) were associated with improved survival on multivariable Cox proportional hazards analysis.
In this cohort of patients with surgically treated laryngeal SCC, multidisciplinary evaluation and elective neck dissection yield of 18 lymph nodes or more are associated with improved survival. Development of better quality metrics is necessary because increased compliance with metrics described by the AHNS and NCCN is not associated with improved survival. Previously described metrics for surgically treated oral cavity cancer are not prognostic for surgically treated laryngeal SCC. Future multi-institutional collaboration will be required to validate these findings, develop better quality metrics, and evaluate whether quality metrics for head and neck cancer are site specific.
喉鳞状细胞癌(SCC)患者存在质量指标,但遵守这些指标是否与生存率提高相关尚不清楚。
研究遵守提议的质量指标是否与接受手术治疗(有或无辅助治疗)的喉SCC患者生存率提高相关。
设计、设置和参与者:这项回顾性队列研究纳入了一家三级医疗学术医学中心的患者,这些患者之前未接受过治疗的喉SCC,于2003年1月1日至2012年12月31日接受了手术治疗(有或无辅助治疗)。数据分析于2015年8月4日至2015年12月13日进行。
有或无辅助治疗的手术。
评估了符合美国头颈学会(AHNS)、国家综合癌症网络(NCCN)指南的质量指标以及具有表面效度的机构指标,这些指标涵盖治疗前评估、治疗和治疗后监测。使用Cox比例风险分析探讨了遵守指标组与总生存期(OS)、疾病特异性生存期(DSS)和无病生存期(DFS)之间的关联。同样确定了遵守个体指标与生存率之间的关联。
该研究共纳入243例患者(184例男性和59例女性)(中位年龄62岁;年龄范围23 - 87岁)。未发现遵守AHNS或NCCN指标水平的提高与生存率之间存在关联。在多变量Cox比例风险分析中,控制pT分期、pN分期、包膜外扩散、切缘状态和合并症后,唯一与生存率提高相关的AHNS或NCCN指标是cT3 - 4期或cN1 - 3期疾病患者的治疗前多学科评估(OS调整风险比[aHR],0.47;95%CI,0.24 - 0.94;DFS aHR,0.45;95%CI,0.23 - 0.85)。对于机构指标,所有患者的多学科评估(OS aHR,0.51;95%CI,0.29 - 0.88;DFS aHR,0.50,95%CI,0.32 - 0.80)以及选择性颈清扫获得18个或更多淋巴结(DFS aHR,0.36;95%CI,0.14 - 0.99)在多变量Cox比例风险分析中与生存率提高相关。
在这组接受手术治疗的喉SCC患者中,多学科评估以及选择性颈清扫获得18个或更多淋巴结与生存率提高相关。由于遵守AHNS和NCCN描述的指标增加与生存率提高无关,因此有必要制定更好的质量指标。先前描述的手术治疗口腔癌的指标对手术治疗的喉SCC无预后价值。未来需要多机构合作来验证这些发现,制定更好的质量指标,并评估头颈癌的质量指标是否具有部位特异性。